22 May 2015

Klaricid XL (Clarithromycin) - United Kingdom

ATC: J01FA
ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
Klaricid XL tablets

Generic Matches for Clarithromycin (3)
Klaricid Adult Sachet
Klaricid Paediatric Suspension
Klaricid 500mg tablets

Last Updated on 22 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Klaricid XL tablets Indication

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Klaricid XL 500 mg Tablets are indicated in adults and children 12 years and older.

Klaricid XL 500 mg Tablets is indicated for treatment of infections caused by susceptible organisms. Indications include:

Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia.

Upper respiratory tract infections for example, sinusitis and pharyngitis.

Klaricid XL 500 mg Tablets is also indicated in skin and soft tissue infections of mild to moderate severity, for example folliculitis, cellulitis and erysipelas.

 

Klaricid XL tablets Generic Name

Clarithromycin

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Klaricid XL 500 mg Tablets (external site)

Related Learning Zones

Anti-Coagulation Video Channel

Anti-Coagulation Video Channel

The Anticoagulation Video Channel is regularly updated with expert videos discussing how to prevent stroke and systemic embolism in non-valvular atrial fibrillation (AF) patients and how to prevent and treat venous thromboembolism (VTE). This free resource is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with AF or VTE.

This resource has been developed in collaboration with Boehringer Ingelheim.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Klaricid XL Marketing Information

Klaricid XL Generic Name
Clarithromycin
Marketing Company
Abbott Laboratories Limited
Drug Type
POM
Date of Issue, Marketing Authority 01/12/1996

Related Drugs - Infectious Diseases

Back to top